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Keratitis-Ichthyosis-Deafness Syndrome-Associated
Cx26 Mutants Produce Nonfunctional Gap Junctions
but Hyperactive Hemichannels When Co-Expressed
With Wild Type Cx43
Isaac E. Garcı´a1, Jaime Maripilla´n1, Oscar Jara1, Ricardo Ceriani1, Angelina Palacios-Mun˜oz1,
Jayalakshmi Ramachandran2, Pablo Olivero3, Tomas Perez-Acle1,4, Carlos Gonza´lez1, Juan C. Sa´ez1,5,
Jorge E. Contreras2 and Agustı´n D. Martı´nez1
Mutations in Cx26 gene are found in most cases of human genetic deafness. Some mutations produce syndromic
deafness associated with skin disorders, like the Keratitis-Ichthyosis-Deafness syndrome (KID). Because in the
human skin connexin 26 (Cx26) is co-expressed with other connexins, like Cx43 and Cx30, and as the KID
syndrome is inherited as autosomal dominant condition, it is possible that KID mutations change the way Cx26
interacts with other co-expressed connexins. Indeed, some Cx26 syndromic mutations showed gap junction
dominant negative effect when co-expressed with wild-type connexins, including Cx26 and Cx43. The nature of
these interactions and the consequences on hemichannels and gap junction channel (GJC) functions remain
unknown. In this study, we demonstrate that syndromic mutations, at the N terminus segment of Cx26, change
connexin oligomerization compatibility, allowing aberrant interactions with Cx43. Strikingly, heteromeric
oligomer formed by Cx43/Cx26 (syndromic mutants) shows exacerbated hemichannel activity but nonfunctional
GJCs; this also occurs for those Cx26 KID mutants that do not show functional homomeric hemichannels.
Heterologous expression of these hyperactive heteromeric hemichannels increases cell membrane permeability,
favoring ATP release and Ca2þ overload. The functional paradox produced by oligomerization of Cx43 and Cx26
KID mutants could underlie the severe syndromic phenotype in human skin.
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INTRODUCTION
Gap junction channels (GJCs) allow metabolic and electrical
coupling between adjacent cells and are formed by the oligo-
merization of connexin (Cx) protein subunits. Cxs oligomerize
to form hexamers called hemichannels (HCs), which reach the
appositional plasma membrane and dock with other
complementary HCs provided by an adjacent cell to form
gap junction plaques (Segretain and Falk, 2004). In non-appo-
sitional plasma membrane, HCs connect the cytoplasm with
the external milieu, allowing paracrine and autocrine signal-
ing mediated by ATP and Ca2þ , among others (Stout et al.,
2004; Sa´ez et al., 2005). HCs can be homomeric, if all
subunits are the same Cxs or heteromeric if they are formed by
two or more different Cxs; however, some Cxs are incom-
patible to form heteromeric channels, like Cx26 and Cx43
(Gemel et al., 2004; Martı´nez et al., 2011; Jara et al., 2012).
Indeed, heteromeric channels have different functional
properties compared with homomeric channels; therefore,
regulation of Cx–Cx interaction could be important in con-
trolling intercellular communication (Martı´nez et al., 2002;
Martinez et al., 2011; Jara et al., 2012).
Mutations in the human Cx26 gene account for about 50%
of genetic deafness. To date, more than 100 Cx26 mutations
have been identified, but only 16 of them, mainly located at
the N terminus and the transition between the first transmem-
brane segment and the extracellular loop segment, cause the
syndromic phenotype (Martı´nez et al., 2009). Although syn-
dromic Cx26 mutations are sparse, they have an autosomal
dominant inheritance pattern that affects proliferation and
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differentiation of skin keratinocytes and produces progressive
corneal neovascularization and hair and nail dystrophies like
in the Keratitis-Ichthyosis-Deafness (KID) syndrome (Ca´ceres-
Rı´os et al., 1996; Kelsell et al., 2000; Arita et al., 2006). It is
hypothesized that syndromic mutations produced gain-of-
function HCs (Gerido et al., 2007; Lee et al., 2009; Sa´nchez
et al., 2010; Levit et al., 2012). However, some syndromic
mutations, like Cx26S17F, lead to nonfunctional HCs, but they
still developed a severe KID syndrome phenotype (Richard
et al., 2002; Mazereeuw-Hautier et al., 2007; Lee et al., 2009).
Most of these studies have been performed in homomeric
HCs, which may not reproduce what occurs in the disease. In
human skin, Cx26 is co-expressed with Cx43, Cx30, and Cx31
(Salomon et al., 1994); as the KID syndrome is inherited
as autosomal dominant condition, it is possible that KID
mutations change the interaction and functional properties
of Cx26 with other Cxs. Thus, to better understand the disease
mechanisms, it is necessary to investigate the effect of Cx26
KID mutations when co-expressed with other Cxs found in the
human skin.
Here, we functionally analyzed several N terminus Cx26
mutants that were co-expressed, or not, with wild-type Cx26
and Cx43. We focused on N14Y and S17F syndromic
mutations, as well as two mutations located at residue 12
that can cause syndromic (G12R) or non-syndromic (G12V)
deafness. The residue G12 is located inside the pore at the
plasma membrane level (Maeda et al., 2009; Kwon et al.,
2011), whereas residues N14 and S17 face the cytoplasm in
the hinge region of the Cx26 N terminus (Figure 1a1). The
effect of two non-syndromic mutations, V37I and A40G,
positioned at the TM1/ECL1 transition, was also assessed to
compare interactions with wild-type Cx26 and Cx43.
RESULTS
Non-syndromic and syndromic mutations located at the
N terminus segment of Cx26 reduce or eliminate GJC formation
and/or function
To assess the effect of Cx26 mutations on traffic, oligomeriza-
tion, and functional state of GJCs, HeLa cells were transfected
with wild-type Cx26 (Cx26 hereinafter) or deafness mutants
attached to green fluorescent protein (GFP) to visualize their
subcellular localization. All transfections were performed in a
HeLa parental cell line that either does not express Cx26 and
Cx43 (Supplementary Figure S1a online) or does not show GJC
currents (Supplementary Table S1 online), confirming that this
cell line is Cx-expression deficient. In contrast, we observed
large GJ plaques in HeLa cells expressing Cx43, Cx26
(Supplementary Figure S1b online), Cx26-GFP or the non-
syndromic Cx26G12V-GFP mutant (Figure 1a2,3) similar to
that previously reported for non-syndromic mutants Cx26V37I
and Cx26A40G (Jara et al., 2012). Conversely, syndromic
mutants formed few GJ plaques, suggesting intracellular
trapping or preferential localization in non-appositional
plasma membrane (Figure 1a4–6 and b).
We next evaluated the functional state of GJCs formed by
homomeric mutations at the N terminus. Dye-transfer and
transjunctional conductance (gj), between cells expressing
syndromic or non-syndromic mutants, were indistinguishable
from those obtained in untransfected cells (Supplementary
Table S1 online). Thus, these mutations completely abolished
the formation of functional GJCs.
Syndromic N terminus mutations affect Cx26 oligomerization
Diffuse cytoplasmic and/or perinuclear localizations
(Figure 1a4–6) identified for syndromic mutants may reflect
partial intracellular trapping because of defective protein
oligomerization. This possibility was analyzed by velocity
sedimentation assays in sucrose gradients. We found that
the oligomeric and monomeric fractions of Cx26-GFP,
Cx26G12V-GFP, and Cx26G12R-GFP present similar sedi-
mentation patterns to Cx26 (Figure 1c–f), which was consis-
tent with those reported previously (Gemel et al., 2004; Jara
et al., 2012). However, for syndromic mutants Cx26N14Y-
GFP and Cx26S17F-GFP (Figure 1g–h), their oligomeric
fractions shifted to lower sucrose densities, suggesting the
formation of intermediate arrangements with fewer hexamers.
To identify a potential dominant negative effect of Cx26
mutants on Cx26 GJC function, we co-expressed the GFP-
tagged mutants with Cx26 containing a hemagglutinin (HA)
tag (Cx26-HA). In these cells, all mutants co-localized with
Cx26-HA and formed abundant and large GJ plaques between
pairs of co-expressing cells (Supplementary Figure S2a–f
online), suggesting that Cx26 rescues the traffic and delivery
of syndromic mutants to appositional areas. Interestingly, all N
terminus mutants, either syndromic or non-syndromic, were
not negative dominant of Cx26 GJCs. Nevertheless, we cannot
rule out subtle changes in the channel permeability, as we
found that GJCs formed by Cx26 and either syndromic mutant
Cx26N14Y or Cx26S17F showed reduced coupling to Lucifer
yellow (2), but normal coupling to the smaller permeability
tracer neurobiotin (þ1; Supplementary Table S1 online),
suggesting that these channels are less permeable to negatively
charged molecules and/or they have a reduce pore size.
Syndromic mutations in the N terminus change the
oligomerization compatibility of Cx26
Although Cx26 is co-expressed with Cx43 in cochlear cells
(Forge et al., 2003) and skin keratinocytes (Salomon et al.,
1994; Richard, 2000; Beyer et al., 2001; Richard et al., 2002;
Arita et al., 2006), they are incompatible to form heteromeric
channels (Gemel et al., 2004). Hence, we aim to study
whether oligomerization of these incompatible Cxs results in
compatible interactions as consequence of syndromic
mutations located at the N terminus of Cx26. HeLa cells
expressing Cx43 were transiently transfected with Cx26-GFP
or mutants. We found that Cx43 and Cx26-GFP localize at the
same plaques, but segregate in different regions (Figure 2a1–
4), which is consistent with their oligomerization incompat-
ibility (Gemel et al., 2004). No co-localization was observed
between Cx43 and the non-syndromic mutants Cx26G12V-
GFP (Figure 2a5–8), Cx26V37I-GFP, or Cx26A40G-GFP
(Supplementary Figure S3 online). However, all syndromic
mutants perfectly co-localized with Cx43 in intracellular
compartments and in GJ plaques (Figure 2a9–20), suggesting
the formation of heteromeric channels. Consistently, Cx
sedimentation analysis showed that only co-expression of
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Cx43 with any syndromic mutant (Figure 2e–g) promoted a
shift in the sedimentation profiles of both proteins to overlap in
a new oligomeric peak, which varied depending on the
protein pair analyzed, confirming the formation of hetero-
meric channels between Cx43 and syndromic mutants. How-
ever, these heteromeric pairs produced nonfunctional GJCs,
suggesting a total transdominant-negative effect of the syn-
dromic mutants on Cx43 GJCs (Supplementary Table S1
online). To rule out that the null GJCs observed under previous
conditions were not consequences of mutant Cx26 over-
expression with respect to Cx43, we did transient transfections
using different ratios of plasmid complementary DNAs carry-
ing Cx43-RFP and Cx26-GFP or its mutant variants (1:1 and
1:0.3 ratios, respectively) and then quantified the fluorescence
for each fluorescent protein to demonstrate the relative
reduction in the expression levels of each mutant Cx26
(Supplementary Figure S4 online). Regardless of the ratio, we
did not observe any junctional coupling in cells co-expressing
Cx43-RFP with any Cx26 syndromic mutant (Supplementary
Table S3 online). Although we cannot estimate the molecular
stoichiometry, our experiments suggest that the negative
dominant effect of syndromic mutant over Cx43 GJC is strong.
In addition, a previous report by Rouan and colleagues also
showed that Cx26 with a syndromic mutation in TM1/EL1 is
a negative dominant of Cx43 GJCs (Rouan et al., 2001),
suggesting that interaction with Cx43 would be a general
feature of syndromic Cx26 mutants.
Syndromic mutations G12R and N14Y, but not S17F, produce
homomeric HCs with gain of function
Because syndromic mutations are linked to gain in HC func-
tion, we performed YO-PRO uptake assays to address HC
function. Under physiological extracellular Ca2þ concentra-
tion, HCs are preferentially closed; however, cells that
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Figure 1. Syndromic mutations reduce or eliminate gap junction channel (GJC) formation. (a1) TM1 and NT of two Cx26 subunits with highlighted residues at the
NT that are linked to deafness mutations. Yellowish rectangle indicates plasma membrane region. (a2–6) Confocal images show the respective subcellular
localization of cells expressing Cx26 wild-type or mutants. White arrows indicate GJ plaques. Arrowheads indicate perinuclear labeling. Bar ¼ 15mm. (b)
Percentage of paired cells expressing GJ plaques per condition. (***Po0.001; n¼ 5, 250 paired cells for condition). (c–h) Syndromic mutations, N14Y and S17F,
affect oligomerization. Graphs represent the sedimentation profile of monomer and oligomers (in arbitrary units of Cx amount; a.u.) of WT or mutants Cx26. SDS
treated fractions (red triangles). Black-filled arrows in (c) show the hexameric peak, and the unfilled arrows show monomeric peaks. Light blue columns indicate
where WT Cx26 hexamers sedimented (n¼ 4). Cx, connexin; GFP, green Fluorescent Protein; GJC, gap junction channel; WT, wild type.
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expressed the syndromic mutants Cx26G12R-GFP or
Cx26N14Y-GFP showed uptake rates that were B10 and
B4 times greater compared with what was observed in cells
expressing Cx26-GFP, respectively, suggesting that both
mutants increased the activity of homomeric HCs enhancing
permeation to positively (þ2) charged molecules (Figure 3b–
c). This result is consistent with previous reports, indicating
that Cx26G12R mutation produces high HC activity in the
presence of physiological extracellular Ca2þ concentrations
(Lee et al., 2009). To further examine the presence of HCs in
the cell membrane, dye uptake was evaluated in divalent
cation-free Hanks’ balanced salt solution (DCF-HBSS), which
enhances HC activity, or in the presence of the lanthanum
ions (La3+), a widely used HC blocker (Figure 3a). In this
condition, YO-PRO uptake was significantly increased in cells
that expressed Cx26 or all the mutants, except for Cx26S17F-
GFP (Figure 3a and d). Conversely, YO-PRO uptake was
partially or completely reduced in the presence of La3+ in
wild-type and mutant HCs (Figure 3a). The variation in YO-
PRO uptake was neither related to differences in expression
levels (Supplementary Figure S1c online) nor depended on the
expression levels of the mutants as revealed by the correlation
analysis of the relative-uptake rate/GFP-expression ratio
(Supplementary Figure S5a online).
A significant increase in YO-PRO uptake under normal
extracellular Ca2þ concentration was recorded in cells that
co-expressed Cx26 with Cx26G12R-GFP or Cx26S17F-GFP.
Such increase was several times greater when compared with
their respective homomeric counterparts or cells co-expressing
Cx26 and Cx26-GFP (Figure 3e–h). Nevertheless, HCs
composed by Cx26 and Cx26G12V-GFP or syndromic
Cx26N14Y-GFP were less active compared with their respec-
tive homomeric conformations and Cx26/Cx26-GFP HCs,
which would reflect the formation of inactive HCs. Correlation
analysis indicates that levels of YO-PRO uptake observed
were not related to differences in expression levels
(Supplementary Figure S5b online).
Syndromic mutants form hyperactive heteromeric HCs with
Cx43
We found no significant difference in YO-PRO uptake in cells
co-expressing Cx43 with Cx26-GFP or with non-syndromic
mutants Cx26G12V-GFP (Figure 3j–k), Cx26V37I-GFP, or
Cx26A40G-GFP (Supplementary Figure S3c online). In
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contrast, uptake mediated by heteromeric HCs formed by all
syndromic mutants with Cx43 showed higher uptake, even in
the presence of divalent cations (Figure 3j–k), which was
boosted after the removal of extracellular Ca2þ (Figure 3i and l),
suggesting that these heteromeric HCs are still sensitive to
Ca2þ . The effects described here were not a consequence of
different expression levels of Cx26 mutants, because they
were observed even in cells that express low levels of
syndromic mutant Cxs (Supplementary Figure S5c online).
To unequivocally assess those Cx26 mutations that increase
HC activity when forming homomeric and heteromeric HCs,
we performed electrophysiological studies using the two-
electrode voltage clamp technique. Macroscopic currents
were elicited by depolarizing pulses in Xenopus laevis oocytes
expressing homomeric and heteromeric HCs, to examine the
current–voltage relationship. Consistent with previous reports
(White et al., 1999; Hansen et al., 2014), oocytes expressing
human Cx43 did not exhibit detectable HC macroscopic
currents (Figure 4a). The lack of HC currents was also
observed in oocytes expressing Cx26G12V, Cx26N14Y, or
Cx26S17F alone (Supplementary Figure S6 online). To evalu-
ate heteromeric HC currents, equal amounts of complementary
RNA were co-injected in oocytes to obtain 1:1 protein express-
ion ratios. Co-expression of Cx43 with the non-syndromic
G12V mutant did not elicit HC currents (Figure 4c and g),
supporting our previous interpretation that these proteins
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do not interact. Conversely, co-expression of Cx43 with the
syndromic Cx26G12R and Cx26S17F mutants promotes larger
HC currents (Figure 4d and f). Lower HC currents were
detected in oocytes co-expressing Cx43 and the Cx26N14Y
mutant (Figure 4e); yet, they were significantly larger at high
positive potentials (450mV) compared with those observed
for oocytes expressing Cx43 or Cx26N14Y alone. Co-expres-
sion of Cx26 and Cx43 showed HC currents with similar
kinetic to those previously described for Cx26 alone (Lopez
et al., 2013a, 2013b).
Expression of heteromeric channels formed by Cx26 syndromic
mutants and Cx43 promotes intracellular Ca2þ overload and
ATP release
Compelling evidence has indicated the existence of a strong
relationship between HC activity and increments in
intracellular Ca2þ concentration and ATP release (Stout
et al., 2002; Saez et al., 2010; Fiori et al., 2012), both are
important for normal functioning of the cochlea and the skin
(Djalilian et al., 2006; Anselmi et al., 2008). To determinate
changes in basal cytosolic Ca2þ levels from HeLa cells
expressing homomeric and heteromeric HCs, cells loaded
with the non-ratiometric probe Fura-Red were incubated in
normal extracellular solution. Only cells that co-expressed
Cx43 with syndromic mutants showed higher intracellular
Ca2þ signal, which was almost saturated as indicated by
treating these cells with 10mM ionomycin that only produced a
minor increase in the Ca2þ signal (Figure 5a and b). Because
Fura-Red has very limited sensitivity to Ca2þ concentration
(above 1mM), we also used Indo-1AM to more accurately
estimate changes in the intracellular Ca2þ concentration
among different mutants. HeLa cells expressing homomeric
HCs, formed by Cx26G12R or Cx26N14Y mutants, but not
Cx26S17F, exhibit higher levels of intracellular Ca2þ when
compared with HeLa cells expressing homomeric wild-type
Cx26 (Supplementary Figure S7 online). Consistently with the
Ca2þ overload reported by the Fura-Red experiments, cells
co-expressing Cx43 with any syndromic mutants showed
elevated intracellular Ca2þ concentration. In particular, cells
co-expressing Cx43 and Cx26S17F display intracellular Ca2þ
levels almost twofolds compared with those measured in cells
co-expressing the wild-type counterparts (Figure 5c).
Because extracellular ATP release correlates with HC
activity (Stout et al., 2002), we explore the basal HC-
dependent ATP release. As expected for hyperactive HCs, we
found more ATP release from cells expressing heteromeric
HCs formed by Cx43 with any syndromic Cx26 mutants
(Figure 5d).
DISCUSSION
In the present work, we propose a possible molecular
mechanism that might underlie the severity of the KID
syndrome by mutations at the N terminus segment of Cx26.
We demonstrate that Cx26 syndromic mutations produce
aberrant Cx–Cx interactions leading to the formation of
heteromeric HCs and GJCs with Cx43. These heteromeric
HCs, but not GJCs, present exacerbate activity (gain in
function) that may lead to dysfunction of paracrine signaling
and Ca2þ overload (Figure 5; Supplementary Table S4 online).
Although KID syndromic mutations have been previously
associated with hyperactive HCs, some syndromic mutations
formed inactive homomeric HCs contradicting the previous
mechanistic explanation for the disease. Because both, Cx26
and Cx43, are highly expressed in the human skin (Salomon
et al., 1994), we propose that all syndromic mutations at the N
terminus could produce the functional paradox of hyperactive
heteromeric HCs (Cx43/Cx26 mutants), but nonfunctional
GJCs (Supplementary Table S4 online), which can worsen the
skin damage in patients carrying these mutations (Mazereeuw-
Hautier et al., 2007).
At the molecular level, our data demonstrate a critical role
of the N terminus in controlling Cx oligomerization. We found
that mutations facing the cytoplasmic environment (i.e.,
Cx26N14Y and Cx26S17F) disrupt the proper formation of
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Figure 4. Heteromeric hemichannels (HCs) composed of Cx43 and the
syndromic mutants produce large macroscopic currents. Membrane currents
from oocytes expressing Cx43 alone or Cx43 with Cx26 mutants were
recorded using the two-electrode voltage clamp technique. HC currents were
activated in response to depolarizing voltage steps from a holding potential of
10mV and stepped in 20mV increments from  100mV toþ60mV.
Representative currents traces are showed for hCx43 alone (a) or for hCx43 co-
expressed with wild-type Cx26 (b), hCx26G12V (c), hCx26G12R (d),
hCx26N14Y (e), or hCx26S17F (f). (g) Graphic depicted the macroscopic
current–voltage relationship of heteromeric HCs. The data represent
mean±SEM of at least five independent experiments. Cx, connexin; HC,
hemichannel; hCx43, human Cx43.
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hexamers but still allow the formation of intermediate Cx
oligomers (Figure 1g and h). The latter is consistent with the
formation of Cx26 dimers that depend on TM1 (Jara et al.,
2012) as the first step into the oligomerization process.
However, mutations in the N terminus might affect sub-
sequent steps in hexamer formation, like the check point for
oligomerization compatibility between Cxs. Our results
support the idea that such check point is located in the
Cx26 N terminus, as it has been previously suggested for this
Cx (Lagree et al., 2003; Martı´nez et al., 2009; Jara et al., 2012)
and for acetylcholine receptors (Verrall and Hall, 1992). These
results are consistent with the notion that an intact N terminus
is critical for the formation (Kyle et al., 2008) and proper
functioning of GJCs, as this segment is part of the transjunc-
tional voltage sensor (Verselis et al., 1994) and gating mech-
anism (Barrio et al., 1991; Maeda et al., 2009; Bargiello et al.,
2012).
Consistent with previous studies (Lee et al., 2009) and with
the YO-PRO uptake experiments, we observed that Xenopus
oocytes expressing homomeric Cx26S17F mutants do not
display HC currents upon membrane depolarization. Suggest-
ing that this mutation drastically decreases the open
probability and/or ionic conductance in homomeric HCs.
Similarly, Cx43 when expressed in Xenopus oocytes does
not show macroscopic HC currents, but it does allow uptake
of ethidium bromide (Hansen et al., 2014). Only few single
Cx43 HCs with very low open probability have been detected
in the whole-cell configuration from cells expressing high
levels of Cx43 proteins at the plasma membrane (Contreras
et al., 2003); yet, significant dye uptake is observed over larger
periods of time-video recording (Sa´ez et al., 2005; Sa´ez et al.,
2010). Remarkably, we showed that the co-expression of
Cx43 and Cx26S17F results in large HC currents (Figure 4f),
which can only be explained by formation of heteromeric HCs
between these two Cxs, as supported by co-localization and
velocity sedimentation assays. Similar results were found
when Cx26N14Y and Cx26G12R were co-expressed with
Cx43. Conversely, the non-syndromic mutant Cx26G12V did
not show significant levels of HC currents or dye uptake when
co-expressed with Cx43, consistently with the biochemical
data showing that this mutation does not lead to the formation
of heteromeric HCs with Cx43, but it does interact with wild-
type Cx26, without the formation of hyperactive functional
HCs. Similar results were observed for non-syndromic mutants
Cx26V37I and Cx26A40G.
In the KID syndrome several tissues are affected, but the
most extensive damage is observed at the epidermis, a tissue
in which Cx26 and Cx43 are the main Cxs expressed (Goliger
and Paul, 1994; Salomon et al., 1994; Wiszniewski et al.,
2000), playing a critical role in keratinocytes homeostasis
maintenance and migration from the basal to the cornified
layer (Risek et al., 1992). Overexpression and ectopic expres-
sion of Cx26 are associated with psoriatic plaques and ATP
release, delayed epidermal barrier recovery, and inflammatory
responses (Djalilian et al., 2006). In addition, a KID patient
carrying mutation N14Y present also ectopic skin expression
of Cx26 that co-localized with Cx43 (Arita et al., 2006). In
addition, P2X purinergic receptors are expressed in the skin
and ATP signaling is important for differentiation and pro-
liferative processes in keratinocytes, as well as hyperplasia
induced after skin barrier disruption (Denda et al., 2002). Our
findings show that the expression of syndromic heteromeric
HCs and GJCs increases basal concentrations of intracellular
Ca2þ and ATP release, which is consistent with the notion
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that both signaling agents permeate through HCs (Stout et al.,
2002; Fiori et al., 2012). Our results support the notion that
the KID syndrome involves keratinocyte homeostasis misre-
gulation as consequences of leaky heteromeric HCs but
nonfunctional GJC, which might promote ATP release, intra-
cellular Ca2þ overload, and cell death and/or proliferation
(Figure 5e). Hence, this study supports the idea to use HC
blockers as possible therapeutic agents for this disease.
MATERIALS AND METHODS
Molecular cloning
Wild-type rat Cx26 cDNA (accession: NM_001004099) was cloned
in the pcDNA3.1/CT-GFP-TOPO vector (Invitrogen, Thermo Fisher
Scientific, Waltham, MA). Site-directed mutagenesis was generated
using the Quick-Change II kit (Agilent Technologies; Santa Clara, CA).
For some experiments Cx26 or its variants contain HA epitope tag
appended to their C terminus. Primer sequences are detailed in
Supplementary Table S2 online. DNA was sequenced by Macrogen
(Seoul, Korea) and analyzed using the ‘‘Vector NTI Advance’’
software (Invitrogen).
Immunofluorescence
Parental HeLa cell transfection and immunofluorescence were per-
formed as previously described (Jara et al., 2012). Antibodies against
Cx43, Cx26, and anti-HA were from Invitrogen. Image acquisition
was performed with a Nikon Eclipse C1-Plus confocal microscope.
Image processing and three-dimensional reconstruction were using
the EZ-C1 and the NIS-Elements Viewer 4.0 software, respectively
(Nikon Instruments, Minato-ku, Tokyo, Japan).
Velocity of sedimentation in sucrose gradients and
immunoblotting
Transfected HeLa cells were harvested and lysed as indicated
previously (Jara et al., 2012). Soluble fractions were subjected to
sedimentation velocity through 5–20% (w/v) linear sucrose gradients,
as previously described (Berthoud et al., 2001; Jara et al., 2012). To
determine the percentage of sucrose at which Cx monomers sedi-
ment, Triton X-100 soluble fractions were treated with SDS to
disaggregate the oligomers. After centrifugation for 22 hours at
100,000 g, 250ml-fractions were collected and analyzed by immuno-
blotting as previously described (Martinez et al., 2002; Jara et al.,
2012).
Measurement of GJC activity
Intercellular dye-coupling was performed as previously described
(Martinez et al., 2002; Jara et al., 2012) and visualized with a Nikon
TE-2,000U inverted microscope (Nikon ACT-2U, Tokyo, Japan). The
results are reported as incidence of coupling––that is, the percentage
of microinjections that resulted in tracer diffusion to one or more
adjacent cells. Electrophysiological recordings in pairs of HeLa cells
were conducted with double whole-cell patch clamp essentially as
described in (Jara et al., 2012). Total gap junctional conductance (gj)
was calculated by using the formula (gj¼ Ij/[Vj cell 1Vj cell 2]).
Assessment of HC activity
Cells plated on glass coverslips were bathed in physiological extra-
cellular solution containing 200nM of YO-PRO-1 uptake (375 Dalton/
þ 2) and subjected to dye uptake time-lapse imaging as described
previously (Contreras et al., 2002; Jara et al., 2012). The bath solution
was replaced by Ca2þ–Mg2þ -free solution (DCF-HBSS, Invitrogen)
containing 200nM YO-PRO-1, and, tracer uptake was recorded for
20 minutes, followed by the addition of 100mM LaCl3 (Sigma-Aldrich,
St. Louis, MO) for an additional 10 minutes. Regions of interest were
obtained with a original magnification  40 objective in a Nikon TE-
2,000U inverted microscope and captured with a Nikon DS-2WBc
fast-cooled monochromatic digital camera (8-bit) every 60 seconds.
Image analysis and quantification of fluorescence intensity were
performed with Image J (http://rsbweb.nih.gov/ij/).
Molecular cloning and HC electrophysiology
Wild-type human Cx26 cDNA was purchased from (Origene; Rock-
ville, MD) and was subcloned in the pGEM-HA vector (Promega;
Madison, WI) for in vitro translation. Mutations of human Cx26 were
produced with Quick-Change II Site-Directed Mutagenesis kits
(Agilent Technologies). DNA sequencing performed at the New
Jersey Medical School Molecular Resource Facility confirmed the
amino acid substitutions. Nhe1-linearized human Cx26 wild-type,
Cx43 and mutant DNAs were transcribed in vitro to cRNAs using the
T7 Ultra mMessage Machine kit (Ambion, Thermo Fisher Scientific,
Waltham, MA). Electrophysiological data were collected using the
two-electrode voltage-clamp technique as in our previous studies
(Lopez et al., 2013a).
Ca2þ imaging
Ionomycin-induced Ca2þ overload was measured by imaging of
Fura-Red acetoxymethylester (Invitrogen). Briefly, HeLa cells growing
in coverslips were loaded with 15mM Fura-red for 20 minutes
at room temperature. Each coverslip was placed in a perfusion
chamber mounted on an IX81 inverted epifluorescence microscope
(Olympus, Shinjuku, Tokyo, Japan) equipped with a 40 /1.4
numerical aperture oil-immersion objective. Image analysis was
performed using the Excellent Pro software. The relative fluorescence
ratio was calculated by dividing fluorescence (F) at each time point by
the initial fluorescence value (F0).
Intracellular Ca2þ concentration was measured using Indo-1AM
(Molecular Probes, Invitrogen; Thermo Fisher Scientific) based on the
standard ratio method (Grynkiewicz et al., 1985; Jacquemond, 1997).
Briefly, HeLa cells growing in 25mm coverslips were loaded with
5mM Indo-1AM (dissolved in 20% pluronic acid in DMSO) for
30 minutes at 37 1C in normal extracellular solution. Each coverslip
was placed in a perfusion chamber mounted on the stage of a
microscope (Diaphot 200-Nikon) equipped with a photomultiplier
(Micron System, MS878; NJ). Indo-1 signals were amplified with an
EPC 10-USB amplifier (HeKa Electronics; Harvard Biosciences,
Holliston, MA). Analog/digital signal conversion was performed
with a DigiData 1,200 Series card (Axon Instruments; Molecular
Devices; Sunnyvale, CA). The Patch Master program (HeKa
Electronics) was used for data acquisition, and data analysis was
carried out with the Igor6 software.
Extracellular ATP measurements
ATP release was assessed with the luciferin/luciferase-based ATP
Determination Kit (Molecular Probes, Invitrogen). Briefly, for each
condition, 50,000 cells/well were seeded in a 24-well plaque.
Twenty-four hours later, the culture medium was washed out and
replaced with Hanks’ balanced salt solution containing 1.8mM Ca2þ ,
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and cells were incubated for 10 minutes at 37 1C. Subsequently,
5ml samples of extracellular milieu were mixed with 45ml ATP-mix
solution in a 96-well plaque. Accumulated ATP was determined using
an Appliskan Luminometer (Thermo Electro; Thermo Fisher Scientific)
based on a calibration curve range from 1nM to 1mM ATP. Data were
collected with the SkanIT software (Thermo Electro).
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